Improvement of the therapeutic treatment of inflammatory bowel diseases following rectal administration of mesalazine-loaded chitosan microparticles vs Asamax®
Mesalazine preparations
Mesalazine alveolitis
Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity
Mesalazine during pregnancy
Mesalazine-associated thrombocytopenia
Fatal aplastic anaemia after mesalazine
Filgrastim for mesalazine-associated neutropenia
Fatal myocarditis associated with mesalazine
Antilymphocyte globulin for mesalazine-associated aplastic anaemia
